Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The United States speciality generics market attained a value of almost USD 26.28 billion in the year 2023. The market is further expected to grow at a CAGR of 9.6% between 2024 and 2032 to reach a value of almost USD 59.97 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States speciality generics market is driven by the rising prevalence of chronic diseases. The industry has witnessed a huge growth in the United States, owing to a growing number of rare disease cases. The industry is thriving in the country with the launch of products by many key industry players, in confluence with the favourable initiatives undertaken by the US FDA like the Breakthrough Therapy, which aims to expand and smoothen the accessibility of these drugs to patients.
Speciality drugs are referred to as drugs that require special handling, supervision, or administration. These drugs usually have complex chemical structures and delivery mechanisms, often requiring extensive research and development (R&D). Speciality generics are the generic variants of such branded drugs that have lost the protection of their patent. These prescription medicines are used in the treatment of chronic medical conditions such as cancer, psoriasis, epilepsy, HIV, hepatitis C, multiple sclerosis, rheumatoid arthritis, haemophilia, and inflammatory bowel disease (IBD).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is segmented on the basis of route of administration into:
Among these, injectables represent a clear dominance in the industry.
On the basis of therapeutic application, the industry is divided into:
Currently, oncology holds the majority of the speciality generics market share in the United States.
On the basis of the distribution channel, the industry is segmented into:
At present, retail pharmacies hold the dominant position in the industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The speciality generics industry in the United States is driven by the rising prevalence of several life-threatening diseases, such as cancer and HIV. In addition to this, an increase in the geriatric population throughout the United States has led to the incidences of several complex diseases, which, inadvertently, is creating a positive outlook for the speciality generics industry. Also, as the manufacturing process of speciality generic drugs does not include marketing and development costs, they are available in the industry at a more affordable price point as opposed to their branded counterparts, which is further propelling the growth of the industry.
The report gives a detailed analysis of the following key players in the United States speciality generics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Route of Administration |
|
Breakup by Therapeutic Application |
|
Breakup by Distribution Channel |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the speciality generics market in the United States attained a value of nearly USD 26.28 billion.
The market is projected to grow at a CAGR of 9.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach around USD 59.97 billion by 2032.
The major drivers of the market are rising prevalence of chronic diseases and affordable prices of specialty generics.
The key trends guiding the growth of the speciality generics market includes an increase in the geriatric population and the favourable initiatives undertaken by the US FDA which aim to expand and smoothen the accessibility of these drugs to patients.
Injectables and oral, among others, are the various routes of administration in the market.
Oncology, hepatitis, multiple sclerosis, and HIV, among others, are the leading therapeutic applications of speciality generics in the United States.
Retail pharmacies, specialty pharmacies, and hospital pharmacies are the leading distribution channels in the market.
The major players in the United States speciality generics market are Akorn, Inc., USA Pharmaceuticals & Sports Science, and Amneal Pharmaceuticals LLC., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share